Add to Quick Collection All 3 Results
| Title | Author/Creator | Date | Full Text | Reviewed | |
|---|---|---|---|---|---|
| Phase II trial of tremelimumab (CP-675,206) in patients with advanced refractory or relapsed melanoma | Kirkwood, John M.; Lorigan, Paul; Hersey, Peter; Hauschild, Axel; Robert, Caroline... More | 2010 | — | ||
| Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: the oblimersen melanoma study group | Bedikian, Agop Y.; Millward, Michael; Kirkwood, John M.; Haluska, Frank G.; Pehamberger, Hubert... More | 2006 | — | ||
| Results of a phase III, randomized, placebo-controlled study of sorafenib in combination with Carboplatin and Paclitaxel as second-line treatment in patients with unresectable stage III or stage IV melanoma | Hauschild, Axel; Agarwala, Sanjiv S; Peschel, Christian; Schadendorf, Dirk; Garbe, Claus... More | 2009 | — |